🔴 Neurosense Therapeutics is trading 7.78% down today after announcing a 1-for-20 reverse share split

Neurosense Therapeutics is trading at $0.37, down 7.78%, after announcing a 1-for-20 reverse share split on September 9, 2026.

• The reverse split is likely driving continued selling pressure ahead of implementation
• Outstanding shares will decrease from 37,938,036 to approximately 1,896,902
• Post-split trading begins September 14, 2026; the broader market is also weaker, but the company-specific announcement is the clearer catalyst